BMY
66
-3
FOX
26
-2
RSG
54
4
FFIV
52
3
CTAS
27
3
LLY
67
-6
PPL
77
2
DAL
66
-2
A
37
3
NI
75
3
NFLX
58
4
LOW
24
-4
KIM
50
13
CAT
55
-2
TSN
58
2
EOG
62
6
CCI
39
9
ETN
55
-2
PFE
45
-15
SYY
31
-4
BMY
66
-3
FOX
26
-2
RSG
54
4
FFIV
52
3
CTAS
27
3
LLY
67
-6
PPL
77
2
DAL
66
-2
A
37
3
NI
75
3
NFLX
58
4
LOW
24
-4
KIM
50
13
CAT
55
-2
TSN
58
2
EOG
62
6
CCI
39
9
ETN
55
-2
PFE
45
-15
SYY
31
-4
Financhill
Back

Werewolf Therapeutics, Inc. 10K Form

Buy
57

HOWL
Werewolf Therapeutics, Inc.

Last Price:
$1.00
Seasonality Move:
-2.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HOWL News And Ratings

See the #1 stock for the next 7 days that we like better than HOWL

HOWL Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-11M
Price / Cash Flow: 0
Annual Sales: $0.51
Price / Book: 1.98

Profitability

EPS (TTM): -1.33380
Net Income (TTM): $-60.8M
Gross Margin: $-1.6M
Return on Equity: -134.22%
Return on Assets: -63.58%

Werewolf Therapeutics, Inc. Earnings Forecast

Key Werewolf Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 3 years.

Werewolf Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HOWL
Website: werewolftx.com

Debt

Debt-to-Equity Ratio: 1.52
Current Ratio: 1.62
Quick Ratio: 1.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HOWL Technical Analysis vs Fundamental Analysis

Buy
57
Werewolf Therapeutics, Inc. (HOWL) is a Buy

Is Werewolf Therapeutics, Inc. a Buy or a Sell?